PFE [NYSE]
Pfizer Inc.
IndexS&P 500 P/E7.46 EPS (ttm)5.47 Insider Own0.04% Shs Outstand5.61B Perf Week2.38%
Market Cap230.86B Forward P/E10.80 EPS next Y3.78 Insider Trans-0.50% Shs Float5.61B Perf Month-4.98%
Income31.37B PEG- EPS next Q0.99 Inst Own70.50% Short Float / Ratio0.69% / 1.70 Perf Quarter-23.88%
Sales100.33B P/S2.30 EPS this Y39.30% Inst Trans0.53% Short Interest38.49M Perf Half Y-11.34%
Book/sh17.04 P/B2.39 EPS next Y12.30% ROA16.30% Target Price51.68 Perf Year-24.76%
Cash/sh4.02 P/C10.16 EPS next 5Y-5.45% ROE35.10% 52W Range39.23 - 56.32 Perf YTD-20.36%
Dividend1.64 P/FCF13.54 EPS past 5Y22.70% ROI25.30% 52W High-27.54% Beta0.62
Dividend %4.02% Quick Ratio1.00 Sales past 5Y13.80% Gross Margin65.50% 52W Low4.03% ATR0.83
Employees83000 Current Ratio1.20 Sales Q/Q2.80% Oper. Margin36.40% RSI (14)43.37 Volatility2.11% 1.89%
OptionableYes Debt/Eq0.37 EPS Q/Q30.10% Profit Margin31.30% Rel Volume0.00 Prev Close40.81
ShortableYes LT Debt/Eq0.34 EarningsJan 31 BMO Payout28.60% Avg Volume22.63M Price40.81
Recom2.50 SMA200.25% SMA50-5.70% SMA200-13.69% Volume0 Change0.00%
Mar-06-23Initiated Jefferies Hold $43
Feb-07-23Upgrade Daiwa Securities Neutral → Outperform $51
Jan-26-23Downgrade UBS Buy → Neutral $55 → $47
Jan-17-23Downgrade Wells Fargo Overweight → Equal Weight $54 → $50
Jan-04-23Downgrade BofA Securities Buy → Neutral $60
Dec-13-22Upgrade Goldman Neutral → Buy $47 → $60
Nov-18-22Initiated Credit Suisse Outperform $55
May-23-22Initiated SVB Leerink Mkt Perform $55
Apr-06-22Resumed Morgan Stanley Equal-Weight $55
Jan-05-22Upgrade BofA Securities Neutral → Buy $59 → $70
Show Previous Ratings
Mar-20-23 06:33PM
05:57PM
05:45PM
08:30AM
Mar-19-23 09:15AM
06:43AM Loading…
06:43AM
Mar-18-23 06:29PM
Mar-17-23 04:41PM
12:19PM
12:18PM
12:17PM
11:04AM
10:11AM
10:08AM
08:45AM
07:30PM Loading…
Mar-16-23 07:30PM
04:30PM
03:18PM
03:16PM
11:20AM
09:53AM
09:52AM
09:40AM
09:33AM
08:35AM
05:52AM
Mar-15-23 03:38PM
02:38PM
10:21AM
09:19AM
08:39AM Loading…
08:39AM
04:54AM
Mar-14-23 10:20PM
07:01PM
05:45PM
04:48PM
03:14PM
03:14PM
02:29PM
02:00PM
12:42PM
11:45AM
10:24AM
09:39AM
09:24AM
09:06AM
09:00AM
04:53AM
12:54AM
Mar-13-23 07:30PM
07:15PM
04:10PM
04:08PM
03:18PM
03:06PM
02:36PM
02:20PM
01:37PM
01:16PM
12:25PM
12:14PM
12:06PM
11:48AM
11:39AM
11:09AM
10:19AM
10:07AM
09:17AM
07:31AM
07:31AM
07:19AM
07:08AM
07:04AM
06:54AM
06:45AM
06:08AM
06:00AM
Mar-11-23 06:14AM
Mar-10-23 10:52AM
10:29AM
07:05AM
06:54AM
06:45AM
06:28AM
Mar-09-23 09:37AM
06:51AM
04:56AM
03:00AM
Mar-08-23 05:45PM
08:15AM
08:13AM
05:30AM
03:03AM
Mar-07-23 11:00AM
10:33AM
08:02AM
06:11AM
Mar-06-23 12:29PM
08:00AM
Mar-05-23 08:30AM
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Retacrit, Lorbrena, and Braftovi brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DAMICO JENNIFER B.SVP & ControllerMar 15Sale40.029,912396,6789,003Mar 17 04:53 PM
SUSMAN SALLYExecutive Vice PresidentFeb 25Option Exercise22.8972,9841,670,604209,179Feb 28 05:52 PM
JOHNSON RADY AExecutive Vice PresidentFeb 25Option Exercise22.8933,654770,340116,473Feb 28 05:52 PM
Hwang AngelaPresident, Global BiopharmaFeb 25Option Exercise22.8920,273464,04944,541Feb 28 05:52 PM
McDermott MichaelExecutive Vice PresidentFeb 25Option Exercise22.8914,178324,53493,099Feb 28 05:52 PM
DAMICO JENNIFER B.SVP & ControllerFeb 25Option Exercise22.8911,150255,22427,893Feb 28 05:52 PM
SUSMAN SALLYExecutive Vice PresidentFeb 22Option Exercise30.1776,0432,294,217195,493Feb 24 09:17 PM
Hwang AngelaPresident, Global BiopharmaceuFeb 22Option Exercise30.1757,0321,720,65567,027Feb 24 09:34 PM
JOHNSON RADY AExecutive Vice PresidentFeb 22Option Exercise30.1731,558952,105106,556Feb 24 08:27 PM
SAHNI PAYALExecutive Vice PresidentFeb 22Option Exercise30.1715,209458,85632,671Feb 24 09:03 PM
McDermott MichaelExecutive Vice PresidentFeb 22Option Exercise30.1713,307401,47288,957Feb 24 08:52 PM
DAMICO JENNIFER B.SVP & ControllerFeb 22Option Exercise30.1710,456315,45821,584Feb 24 08:14 PM
BOURLA ALBERTChairman & CEODec 16Option Exercise27.25222,3286,058,580411,890Dec 16 06:14 PM
LANKLER DOUGLAS MExecutive Vice PresidentDec 14Option Exercise26.29101,6582,672,548180,461Dec 16 06:14 PM
Dolsten MikaelPresident R&DNov 07Option Exercise33.2179,1082,627,260420,007Nov 09 04:08 PM
DAMICO JENNIFER B.SVP & ControllerJun 07Sale53.964,218227,60310,846Jun 08 04:43 PM
DAMICO JENNIFER B.SVP & ControllerMay 16Sale50.504,000202,00015,064May 17 07:48 AM
SAHNI PAYALExecutive Vice PresidentMay 13Sale49.841,40870,17517,372May 16 09:23 PM
LANKLER DOUGLAS MExecutive Vice PresidentMay 12Sale49.4138,2731,891,06978,803May 13 05:19 PM
Carapezzi William R JRExecutive Vice PresidentMay 12Sale50.0032,9081,645,40038,146May 13 05:38 PM
Dolsten MikaelPresident R&DMay 11Sale49.3263,9023,151,547333,342May 12 04:34 PM